GSK Q4 Earnings: Revenue & EPS Beat, $2.5B Buyback, & Long-Term Forecast Boost

No views

Daily Stock News

9 days ago

GSK Q4 Earnings: Revenue & EPS Beat, $2.5B Buyback, & Long-Term Forecast Boost

GSK Q4 Earnings: Revenue & EPS Beat, $2.5B Buyback, & Long-Term Forecast Boost